The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

These are called autoantibodies. In a 2015 study in the journal Arthritis and Rheumatology, a group of Canadian researchers ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...

Autoimmune diseases like lupus rheumatoid arthritis and psoriasis don’t just affect joints or skin they can silently damage ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

Belimumab autoinjector is now approved and available for pediatric patients with lupus nephritis. The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for ...

The US Food and Drug Administration (FDA) has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five years and above with active lupus nephritis (LN), who are currently receiving ...

Music and Chinese period dramas bring comfort to 13-year-old Er Yue Rou, who lives with the autoimmune disease. With help from Make-A-Wish Singapore, she starred in a professionally produced period ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector of Benlysta (belimumab), a B-lymphocyte stimulator (BlyS)-specific ...

The American College of Rheumatology (ACR) has released a summary of a guideline with updated recommendations for the treatment of systemic lupus erythematosus (SLE). The previous guideline for ...

I also direct our Lupus Center of Excellence and I have the privilege of serving as the Medical Director for the Lupus Foundation of America. And I'm here today to tell you some very exciting news.